Monkeypox | NEJM

1. von Magnus P, Andersen EK, Petersen KB, Birch-Andersen A. A pox-like illness in cynomolgus monkeys. Acta Pathol Microbiol Scand 1959;46:156–176.

2. Arita I, Henderson DA. Smallpox and monkeypox in non-human primates. Bull World Well being Organ 1968;39:277–283.

3. Ladnyj ID, Ziegler P, Kima E. A human an infection attributable to monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Well being Organ 1972;46:593–597.

4. Lourie B, Bingham PG, Evans HH, Foster SO, Nakano JH, Herrmann KL. Human an infection with monkeypox virus: laboratory investigation of six circumstances in West Africa. Bull World Well being Organ 1972;46:633–639.

5. Beer EM, Rao VB. A scientific evaluate of the epidemiology of human monkeypox outbreaks and implications for outbreak technique. PLoS Negl Trop Dis 2019;13(10):e0007791–e0007791.

6. Bunge EM, Hoet B, Chen L, et al. The altering epidemiology of human monkeypox — a possible menace? A scientific evaluate. PLoS Negl Trop Dis 2022;16(2):e0010141–e0010141.

7. Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in people within the Western Hemisphere. N Engl J Med 2004;350:342–350.

8. Mauldin MR, McCollum AM, Nakazawa YJ, et al. Exportation of monkeypox virus from the African Continent. J Infect Dis 2022;225:1367–1376.

9. Nguyen PY, Ajisegiri WS, Costantino V, Chughtai AA, MacIntyre CR. Reemergence of human monkeypox and declining inhabitants immunity within the context of urbanization, Nigeria, 2017–2020. Emerg Infect Dis 2021;27:1007–1014.

10. Ogoina D, Izibewule JH, Ogunleye A, et al. The 2017 human monkeypox outbreak in Nigeria — report of outbreak expertise and response within the Niger Delta College Educating Hospital, Bayelsa State, Nigeria. PLoS One 2019;14(4):e0214229–e0214229.

11. Yinka-Ogunleye A, Aruna O, Dalhat M, et al. Outbreak of human monkeypox in Nigeria in 2017-18: a medical and epidemiological report. Lancet Infect Dis 2019;19:872–879.

12. Hobson G, Adamson J, Adler H, et al. Household cluster of three circumstances of monkeypox imported from Nigeria to the UK, Might 2021. Euro Surveill 2021;26:2100745–2100745.

13. Rao AK, Schulte J, Chen T-H, et al. Monkeypox in a traveler coming back from Nigeria — Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep 2022;71:509–516.

14. Antinori A, Mazzotta V, Vita S, et al. Epidemiological, medical and virological traits of 4 circumstances of monkeypox assist transmission by way of sexual contact, Italy, Might 2022. Euro Surveill 2022;27:2200421–2200421.

15. Perez Duque M, Ribeiro S, Martins JV, et al. Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 Might 2022. Euro Surveill 2022;27:2200424–2200424.

16. Vivancos R, Anderson C, Blomquist P, et al. Neighborhood transmission of monkeypox in the UK, April to Might 2022. Euro Surveill 2022;27:2200422–2200422.

17. Kluge H, Ammon A. Monkeypox in Europe and past — tackling a uncared for illness collectively. Euro Surveill 2022;27:2200482–2200482.

18. Moss B. Poxviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields’ virology fifth ed. New York: Lippincott Williams and Wilkins, 2007:2905–2946.

19. Damon IK. Poxviruses. In: Knipe DM, Howley PM, eds. Fields’ virology fifth ed. New York: Lippincott Williams and Wilkins, 2007:2947–2976.

20. Cardeti G, Gruber CEM, Eleni C, et al. Deadly outbreak in tonkean macaques attributable to probably novel orthopoxvirus, Italy, January 2015. Emerg Infect Dis 2017;23:1941–1949.

21. Nice PE, Jezek Z, Seize B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol 1988;17:643–650.

22. Rimoin AW, Mulembakani PM, Johnston SC, et al. Main enhance in human monkeypox incidence 30 years after smallpox vaccination campaigns stop within the Democratic Republic of Congo. Proc Natl Acad Sci U S A 2010;107:16262–16267.

23. Chen N, Li G, Liszewski MK, et al. Virulence variations between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005;340:46–63.

24. Likos AM, Sammons SA, Olson VA, et al. A story of two clades: monkeypox viruses. J Gen Virol 2005;86:2661–2672.

25. Happi C, Adetifa I, Mbala P, et al. Pressing want for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol 2022;20(8):e3001769–e3001769.

26. Doty JB, Malekani JM, Kalemba LN, et al. Assessing monkeypox virus prevalence in small mammals on the human-animal interface within the Democratic Republic of the Congo. Viruses 2017;9:283–283.

27. Khodakevich L, Jezek Z, Kinzanzka Okay. Isolation of monkeypox virus from wild squirrel contaminated in nature. Lancet 1986;1:98–99.

28. Radonić A, Metzger S, Dabrowski PW, et al. Deadly monkeypox in wild-living sooty mangabey, Côte d’Ivoire, 2012. Emerg Infect Dis 2014;20:1009–1011.

29. Tiee MS, Harrigan RJ, Thomassen HA, Smith TB. Ghosts of infections previous: utilizing archival samples to grasp a century of monkeypox virus prevalence amongst host communities throughout area and time. R Soc Open Sci 2018;5:171089–171089.

30. Reynolds MG, Doty JB, McCollum AM, Olson VA, Nakazawa Y. Monkeypox re-emergence in Africa: a name to increase the idea and follow of One Well being. Knowledgeable Rev Anti Infect Ther 2019;17:129–139.

31. Tesh RB, Watts DM, Sbrana E, Siirin M, Popov VL, Xiao SY. Experimental an infection of floor squirrels (Spermophilus tridecemlineatus) with monkeypox virus. Emerg Infect Dis 2004;10:1563–1567.

32. Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: medical options of 282 sufferers. J Infect Dis 1987;156:293–298.

33. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis 2014;58:260–267.

34. Realized LA, Reynolds MG, Wassa DW, et al. Prolonged interhuman transmission of monkeypox in a hospital group within the Republic of the Congo, 2003. Am J Trop Med Hyg 2005;73:428–434.

35. Doshi RH, Guagliardo SAJ, Doty JB, et al. Epidemiologic and ecologic investigations of monkeypox, Likouala division, Republic of the Congo, 2017. Emerg Infect Dis 2019;25:281–289.

36. Berthet N, Nakouné E, Whist E, et al. Maculopapular lesions within the Central African Republic. Lancet 2011;378:1354–1354.

37. Besombes C, Gonofio E, Konamna X, et al. Intrafamily transmission of monkeypox virus, Central African Republic, 2018. Emerg Infect Dis 2019;25:1602–1604.

38. Nakoune E, Lampaert E, Ndjapou SG, et al. A nosocomial outbreak of human monkeypox within the Central African Republic. Open Discussion board Infect Dis 2017;4:ofx168–ofx168.

39. Di Giulio DB, Eckburg PB. Human monkeypox: an rising zoonosis. Lancet Infect Dis 2004;4:15–25.

40. Huhn GD, Bauer AM, Yorita Okay, et al. Scientific traits of human monkeypox, and danger components for extreme illness. Clin Infect Dis 2005;41:1742–1751.

41. Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: epidemiologic and medical traits, prognosis, and prevention. Infect Dis Clin North Am 2019;33:1027–1043.

42. Jezek Z, Szczeniowski M, Paluku KM, Mutombo M, Seize B. Human monkeypox: confusion with chickenpox. Acta Trop 1988;45:297–307.

43. Hutin YJ, Williams RJ, Malfait P, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis 2001;7:434–438.

44. Rimoin AW, Kisalu N, Kebela-Ilunga B, et al. Endemic human monkeypox, Democratic Republic of Congo, 2001–2004. Emerg Infect Dis 2007;13:934–937.

45. Hughes CM, Liu L, Davidson WB, et al. A story of two viruses: coinfections of monkeypox and varicella zoster virus within the Democratic Republic of Congo. Am J Trop Med Hyg 2020;104:604–611.

46. Hoff NA, Doshi RH, Colwell B, et al. Evolution of a illness surveillance system: a rise in reporting of human monkeypox illness within the Democratic Republic of the Congo, 2001–2013. Int J Trop Dis Well being 2017;25:IJTDH.35885–IJTDH.35885.

47. Doshi RH, Alfonso VH, Morier D, et al. Monkeypox rash severity and animal exposures within the Democratic Republic of the Congo. Ecohealth 2020;17:64–73.

48. Nolen LD, Osadebe L, Katomba J, et al. Prolonged human-to-human transmission throughout a monkeypox outbreak within the Democratic Republic of the Congo. Emerg Infect Dis 2016;22:1014–1021.

49. Vandenbogaert M, Kwasiborski A, Gonofio E, et al. Nanopore sequencing of a monkeypox virus pressure remoted from a pustular lesion within the Central African Republic. Sci Rep 2022;12:10768–10768.

50. McMullen CL, Mulembekani P, Hoff NA, et al. Human monkeypox transmission dynamics thirty years after smallpox eradication within the Sankuru district, democratic republic of Congo. Am J Trop Med Hyg 2015;93:341–341.

• Net of Science

Google Scholar

51. Ferré VM, Bachelard A, Zaidi M, et al. Detection of monkeypox virus in anorectal swabs from asymptomatic males who’ve intercourse with males in a sexually transmitted an infection screening program in Paris, France. Ann Intern Med 2022 August 16 (Epub forward of print).

52. Isidro J, Borges V, Pinto M, et al. Phylogenomic characterization and indicators of microevolution within the 2022 multi-country outbreak of monkeypox virus. Nat Med 2022;28:1569–1572.

53. Facilities for Illness Management and Prevention. 2022 monkeypox outbreak international map. September 20, 2022 (https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html).

54. UK Well being Safety Company. Investigation into monkeypox outbreak in England: technical briefing 2. September 2, 2022 (https://www.gov.uk/authorities/publications/monkeypox-outbreak-technical-briefings/investigation-into-monkeypox-outbreak-in-england-technical-briefing-2).

55. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus an infection in people throughout 16 international locations — April–June 2022. N Engl J Med 2022;387:679–691.

56. Kugelman JR, Johnston SC, Mulembakani PM, et al. Genomic variability of monkeypox virus amongst people, Democratic Republic of the Congo. Emerg Infect Dis 2014;20:232–239.

57. Patrocinio-Jesus R, Peruzzu F. Monkeypox genital lesions. N Engl J Med 2022;387:66–66.

58. Patel A, Bilinska J, Tam JCH, et al. Scientific options and novel displays of human monkeypox in a central London centre through the 2022 outbreak: descriptive case collection. BMJ 2022;378:e072410–e072410.

59. Davido B, D’anglejan E, Jourdan J, Robinault A, Davido G. Monkeypox 2022 outbreak: circumstances with unique genital lesions. J Journey Med 2022;29:taac077–taac077.

60. Hammerschlag Y, MacLeod G, Papadakis G, et al. Monkeypox an infection presenting as genital rash, Australia, Might 2022. Euro Surveill 2022;27:2200411–2200411.

61. Tarín-Vicente EJ, Alemany A, Agud-Dios M, et al. Scientific presentation and virological evaluation of confirmed human monkeypox virus circumstances in Spain: a potential observational cohort examine. Lancet 2022;400:661–669.

62. Sklenovská N, Van Ranst M. Emergence of monkeypox as crucial orthopoxvirus an infection in people. Entrance Public Well being 2018;6:241–241.

63. Grosenbach DW, Honeychurch Okay, Rose EA, et al. Oral tecovirimat for the therapy of smallpox. N Engl J Med 2018;379:44–53.

64. Jordan R, Chinsangaram J, Bolken TC, et al. Security and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in wholesome grownup topics. Antimicrob Brokers Chemother 2010;54:2560–2566.

65. Chinsangaram J, Honeychurch KM, Tyavanagimatt SR, et al. Security and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single day by day oral dose for 14 days in human volunteers. Antimicrob Brokers Chemother 2012;56:4900–4905.

66. Adler H, Gould S, Hine P, et al. Scientific options and administration of human monkeypox: a retrospective observational examine within the UK. Lancet Infect Dis 2022;22:1153–1162.

67. Chan-Tack Okay, Harrington P, Bensman T, et al. Profit-risk evaluation for brincidofovir for the therapy of smallpox: U.S. Meals and Drug Administration’s Analysis. Antiviral Res 2021;195:105182–105182.

68. Meals and Drug Administration. Tembexa (brincidofovir): highlights of prescribing info. June 2021 (https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214460s000,214461s000lbl.pdf).

69. Marty FM, Winston DJ, Rowley SD, et al. CMX001 to forestall cytomegalovirus illness in hematopoietic-cell transplantation. N Engl J Med 2013;369:1227–1236.

70. Sherwat A, Brooks JT, Birnkrant D, Kim P. Tecovirimat and the therapy of monkeypox — previous, current, and future concerns. N Engl J Med 2022;387:579–581.

71. French Nationwide Company for Analysis on AIDS. Monkeypox: CORE protocol for a world trial of the security and efficacy of remedies. July 28, 2022 (https://www.anrs.fr/en/actualites/1127/monkeypox-core-protocol-international-trial-safety-and-efficacy-treatments).

72. Wittek R. Vaccinia immune globulin: present insurance policies, preparedness, and product security and efficacy. Int J Infect Dis 2006;10:193–201.

73. WHO Advisory Committee on Variola Virus Analysis. Report of the twenty-third assembly: digital assembly, 3–4 November 2021. Geneva: World Well being Group, 2021 (https://apps.who.int/iris/relaxation/bitstreams/1423719/retrieve).

74. Decker MD, Garman PM, Hughes H, et al. Enhanced security surveillance examine of ACAM2000 smallpox vaccine amongst US army service members. Vaccine 2021;39:5541–5547.

75. Malarkry M, Gruber M. Meals and Drug Administration. Organic License Software approval letter for MVA-BN vaccine, Bavarian Nordic. Silver Spring, MD: Meals and Drug Administration, September 24, 2019 (https://www.fda.gov/media/131079/obtain).

76. Eto A, Saito T, Yokote H, Kurane I, Kanatani Y. Latest advances within the examine of stay attenuated cell-cultured smallpox vaccine LC16m8. Vaccine 2015;33:6106–6111.

77. Le Guludec D. Avis n° 2022.0034/SESPEV du 20 mai 2022 du collège de la Haute Autorité de Santé relatif à la vaccination contre Monkeypox. Haute Autorité de Santé, Might 20, 2022 (https://www.has-sante.fr/add/docs/utility/pdf/2022-05/avis_n2022.0034_sespev_du_20_mai_2022_du_college_de_la_has_relatif_a_la_vaccination_contre_la_variole_du_singe_monkeypox_vir.pdf).

78. UK Well being Safety Company. Monkeypox: vaccine to be provided extra broadly to assist management outbreak. June 21, 2022 (https://www.gov.uk/authorities/information/monkeypox-vaccine-to-be-offered-more-widely-to-help-control-outbreak).